These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21227388)

  • 21. Current attitudes toward carrier screening for spinal muscular atrophy among pregnant women in Eastern China.
    Li Y; Wang L; Tan J; Huang M; Wang Y; Shao B; Lv J; Zhang J
    J Genet Couns; 2023 Aug; 32(4):823-832. PubMed ID: 36775845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Making a (cautious) case for expanding reproductive genetic carrier screens: Australian researchers report success, and caveats, with a simultaneous panel of cystic fibrosis, fragile X syndrome, and spinal muscular atrophy.
    Am J Med Genet A; 2018 Mar; 176(3):510-512. PubMed ID: 29446568
    [No Abstract]   [Full Text] [Related]  

  • 23. Spinal muscular atrophy: molecular genetics and diagnostics.
    Ogino S; Wilson RB
    Expert Rev Mol Diagn; 2004 Jan; 4(1):15-29. PubMed ID: 14711346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced Carrier Screening for Spinal Muscular Atrophy: Detection of Silent (SMN1: 2 + 0) Carriers Utilizing a Novel TaqMan Genotyping Method.
    Azad AK; Huang CK; Jin H; Zou H; Yanakakis L; Du J; Fiddler M; Naeem R; Goldstein Y
    Lab Med; 2020 Jul; 51(4):408-415. PubMed ID: 31875889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of experiential knowledge within attitudes towards genetic carrier screening: A comparison of people with and without experience of spinal muscular atrophy.
    Boardman FK; Young PJ; Warren O; Griffiths FE
    Health Expect; 2018 Feb; 21(1):201-211. PubMed ID: 28703871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SMA carrier testing: a meta-analysis of differences in test performance by ethnic group.
    MacDonald WK; Hamilton D; Kuhle S
    Prenat Diagn; 2014 Dec; 34(12):1219-26. PubMed ID: 25059567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Screening for spinal muscular atrophy mutation carriers among 4931 pregnant women from Liuzhou region of Guangxi].
    Tan J; Zhang X; Wang Y; Luo S; Yang F; Liu B; Cai R
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Aug; 35(4):467-470. PubMed ID: 30098235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treating neonatal spinal muscular atrophy: A 21st century success story?
    Tizzano EF
    Early Hum Dev; 2019 Nov; 138():104851. PubMed ID: 31604576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correspondence on: "Discrepancy in Spinal Muscular Atrophy Incidence findings in newborn screening programs: the influence of carrier screening?" by Kay et al.
    Dangouloff T; Boemer F; Caberg JH; Servais L
    Genet Med; 2020 Nov; 22(11):1913-1914. PubMed ID: 32601389
    [No Abstract]   [Full Text] [Related]  

  • 30. Perspectives in genetic counseling for spinal muscular atrophy in the new therapeutic era: early pre-symptomatic intervention and test in minors.
    Serra-Juhe C; Tizzano EF
    Eur J Hum Genet; 2019 Dec; 27(12):1774-1782. PubMed ID: 31053787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carrier frequency of spinal muscular atrophy in Thailand.
    Dejsuphong D; Taweewongsounton A; Khemthong P; Chitphuk S; Stitchantrakul W; Sritara P; Tunteeratum A; Sura T
    Neurol Sci; 2019 Aug; 40(8):1729-1732. PubMed ID: 31004230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Socioeconomic status and uptake of reproductive carrier screening in Australia.
    Robson SJ; Caramins M; Saad M; Suthers G
    Aust N Z J Obstet Gynaecol; 2020 Dec; 60(6):976-979. PubMed ID: 32748403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ontario Newborn Screening for Spinal Muscular Atrophy: The First Year.
    Kernohan KD; McMillan HJ; Yeh E; Lacaria M; Kowalski M; Campbell C; Dowling JJ; Gonorazky H; Marcadier J; Tarnopolsky MA; Vajsar J; Mackenzie A; Chakraborty P
    Can J Neurol Sci; 2022 Nov; 49(6):821-823. PubMed ID: 34620260
    [No Abstract]   [Full Text] [Related]  

  • 34. Opening the window: The case for carrier and perinatal screening for spinal muscular atrophy.
    Burns JK; Kothary R; Parks RJ
    Neuromuscul Disord; 2016 Sep; 26(9):551-9. PubMed ID: 27460292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expanded carrier screening: A review of early implementation and literature.
    Lazarin GA; Haque IS
    Semin Perinatol; 2016 Feb; 40(1):29-34. PubMed ID: 26718446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spinal muscular atrophy in the neonate.
    Markowitz JA; Tinkle MB; Fischbeck KH
    J Obstet Gynecol Neonatal Nurs; 2004; 33(1):12-20. PubMed ID: 14971549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Newborn genetic screening for spinal muscular atrophy in the UK: The views of the general population.
    Boardman FK; Sadler C; Young PJ
    Mol Genet Genomic Med; 2018 Jan; 6(1):99-108. PubMed ID: 29169204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic testing and risk assessment for spinal muscular atrophy (SMA).
    Ogino S; Wilson RB
    Hum Genet; 2002 Dec; 111(6):477-500. PubMed ID: 12436240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prenatal Carrier Screening for Spinal Muscular Atrophy.
    Wood SL; Brewer F; Ellison R; Biggio JR; Edwards RK
    Am J Perinatol; 2016 Oct; 33(12):1211-7. PubMed ID: 27611803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of spinal muscular atrophy carriers in a sample of the Brazilian population.
    Bueno KC; Gouvea SP; Genari AB; Funayama CA; Zanette DL; Silva WA; Oliveira AB; Scola RH; Werneck LC; Marques W
    Neuroepidemiology; 2011; 36(2):105-8. PubMed ID: 21335981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.